Saira Ramasastry, Director at Vir Biotechnology, Inc. (VIR), sold 3,500 shares at $25.67 ($90K) on 2023-06-01, disclosed to the SEC on 2023-06-02.
Scheduled sale ($90k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MIRM | SELL | 2026-04-16 | $194K | — | Filing → |
| MIRM | SELL | 2026-03-17 | $182K | — | Filing → |
| MIRM | SELL | 2026-02-17 | $204K | — | Filing → |